Press Releases
Mar
10
2016
Jan
05
2016
Dec
16
2015
Intec Pharma Further Expands Intellectual Property With a New Patent for the Accordion Pill Zaleplon in Europe
Dec
14
2015
Intec Pharma Receives an IRB Approval to Initiate Phase III Clinical Trial of AP - CDLD for the Treatment of Parkinson's Disease
Dec
08
2015
Nov
05
2015
Oct
22
2015
Intec Pharma Expands Intellectual Property With a New Patent for the Accordion Pill in Europe
Oct
12
2015
Intec Pharma Announces Topline Results of a Food Effect, Pharmacokinetic Study of AP-CDLD 50/500mg for the Treatment of Parkinson's Disease Symptoms
Sep
17
2015
Intec Pharma Ltd. Announces Partial Exercise of Underwriters Option to Purchase Additional Ordinary Shares
Displaying 111 - 119 of 119